LEADER 01657nam  2200457 a 450 
001 9910699613903321
005 20101025154348.0
035   $a(CKB)5470000002404801
035   $a(OCoLC)671653048
035   $a(EXLCZ)995470000002404801
100   $a20101025d2009      ua             0
101 0 $aeng
135   $aurmn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aHIV Drug Resistance Program$b[electronic resource]
210  1$a[Bethesda, Md.] :$cNational Cancer Institute, U.S. Dept. of Health and Human Services, National Institutes of Health,$d[2009]
215   $a1 online resource (ii, 26 pages) $ccolor illustrations
225 1 $aNIH publication ;$vno. 08-6530
300   $aTitle from title screen (viewed on Oct. 25, 2010).
300   $a"Printed October 2009"--P. [4] of cover.
606   $aHIV infections$xResearch$zUnited States
606   $aHIV infections$xChemotherapy$zUnited States
606   $aHIV (Viruses)$xResearch$zUnited States
606   $aAIDS (Disease)$xResearch$zUnited States
606   $aAIDS (Disease)$xChemotherapy$zUnited States
606   $aDrug resistance$xResearch$zUnited States
615  0$aHIV infections$xResearch
615  0$aHIV infections$xChemotherapy
615  0$aHIV (Viruses)$xResearch
615  0$aAIDS (Disease)$xResearch
615  0$aAIDS (Disease)$xChemotherapy
615  0$aDrug resistance$xResearch
712 02$aNational Cancer Institute (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699613903321
996   $aHIV Drug Resistance Program$93119871
997   $aUNINA